Literature DB >> 2121220

Serine protease-induced enhancement of blood-borne metastasis of rat ascites tumour cells and its prevention with deoxyribonuclease.

S Sugihara1, T Yamamoto, J Tsuruta, J Tanaka, T Kambara, T Hiraoka, Y Miyauchi.   

Abstract

Serine proteases, such as alpha-chymotrypsin or elastase, caused an aggregation of rat ascites tumour cell lines, AH-130, AH-109A and YS, in a protein free medium which preserved the cell viability. This aggregation, which was monitored spectrophotometrically, was dependent upon the protease activities and was resistant to treatment with either a calcium chelating reagent (EDTA) or neuraminidase. However, the tumour cell aggregates were redispersed by treatment with deoxyribonuclease I (DNase I). This dispersal effect was dependent upon the DNase activity. A possible relationship between the tumour cell aggregation and development of blood-borne metastasis was studied. An intravenous inoculation in rats of tumour cell aggregates performed by the alpha-chymotrypsin treatment resulted in significantly higher numbers of lung metastatic foci than an injection of single cells. When the re-separated single cells, prepared in vitro by treatment with DNase I following alpha-chymotrypsin treatment, were injected instead of the aggregates, the enhancement of metastasis was reversed. These enhancement and reversal effects were mimicked in vivo by intravenous injections of protease and nuclease following inoculation of a single cell suspension. That is, the number of metastatic foci caused by single cell inoculation followed by an intravenous alpha-chymotrypsin injection, was higher than that in a control group receiving PBS instead of alpha-chymotrypsin. Again, this augmentation was reversed by an injection of DNase I following alpha-chymotrypsin injection. Furthermore, an injection of DNase I alone itself reduced the starting number of metastases resulting from injection of the single tumour cell suspension. These data suggest that the metastatic behaviour of tumour cells may be increased by protease inducible DNA dependent cell aggregation should it occur in the blood stream.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121220      PMCID: PMC1971483          DOI: 10.1038/bjc.1990.339

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Organ specificity of blood-borne tumour metastasis determined by cell adhesion?

Authors:  G L Nicolson; J L Winkelhake
Journal:  Nature       Date:  1975-05-15       Impact factor: 49.962

2.  "ECM": its nature, origin and function in cell aggregation.

Authors:  M S STEINBERG
Journal:  Exp Cell Res       Date:  1963-04       Impact factor: 3.905

3.  Rotation-mediated histogenetic aggregation of dissociated cells. A quantifiable approach to cell interactions in vitro.

Authors:  A MOSCONA
Journal:  Exp Cell Res       Date:  1961-01       Impact factor: 3.905

4.  The effects of trypsin on the size, viability and dry mass of sarcoma 37 cells.

Authors:  L WEISS
Journal:  Exp Cell Res       Date:  1958-02       Impact factor: 3.905

5.  Accurate identification of experimental pulmonary metastases.

Authors:  H Wexler
Journal:  J Natl Cancer Inst       Date:  1966-04       Impact factor: 13.506

6.  Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine.

Authors:  I J Fidler
Journal:  J Natl Cancer Inst       Date:  1970-10       Impact factor: 13.506

7.  Neutral proteinase inhibitors and antimetastatic effects in mice.

Authors:  T Giraldi; G Sava; M Kopitar; J Brzin; V Turk
Journal:  Eur J Cancer       Date:  1980-04       Impact factor: 9.162

8.  Effect of deoxyribonuclease on the course of lymphatic leukaemia in AKR mice.

Authors:  R I Salganik; R P Martynova; N A Matienko; G M Ronichevskaya
Journal:  Nature       Date:  1967-04-01       Impact factor: 49.962

9.  Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential.

Authors:  B F Sloane; K V Honn; J G Sadler; W A Turner; J J Kimpson; J D Taylor
Journal:  Cancer Res       Date:  1982-03       Impact factor: 12.701

10.  Lodgement and extravasation of tumour cells in blood-borne metastasis: an electron microscope study.

Authors:  M Kinjo
Journal:  Br J Cancer       Date:  1978-08       Impact factor: 7.640

View more
  5 in total

1.  Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps.

Authors:  Juwon Park; Robert W Wysocki; Zohreh Amoozgar; Laura Maiorino; Miriam R Fein; Julie Jorns; Anne F Schott; Yumi Kinugasa-Katayama; Youngseok Lee; Nam Hee Won; Elizabeth S Nakasone; Stephen A Hearn; Victoria Küttner; Jing Qiu; Ana S Almeida; Naiara Perurena; Kai Kessenbrock; Michael S Goldberg; Mikala Egeblad
Journal:  Sci Transl Med       Date:  2016-10-19       Impact factor: 17.956

2.  Identification of prognostic factors associated with early mortality after surgical resection for pancreatic cancer--under-analysis of cumulative survival curve.

Authors:  Hiroshi Takamori; Takehisa Hiraoka; Keiichiro Kanemitsu; Tatsuya Tsuji; Chikuma Hamada; Hideo Baba
Journal:  World J Surg       Date:  2006-02       Impact factor: 3.352

3.  Alteration of the exDNA profile in blood serum of LLC-bearing mice under the decrease of tumour invasion potential by bovine pancreatic DNase I treatment.

Authors:  Ludmila A Alekseeva; Nadezhda L Mironova; Evgenyi V Brenner; Alexander M Kurilshikov; Olga A Patutina; Marina A Zenkova
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

Review 4.  Deoxyribonucleases and Their Applications in Biomedicine.

Authors:  Lucia Lauková; Barbora Konečná; Ľubica Janovičová; Barbora Vlková; Peter Celec
Journal:  Biomolecules       Date:  2020-07-11

5.  Deoxyribonuclease treatment prevents blood-borne liver metastasis of cutaneously transplanted tumour cells in mice.

Authors:  S Sugihara; T Yamamoto; H Tanaka; T Kambara; T Hiraoka; Y Miyauchi
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.